NTLA Intellia Therapeutics, Inc.
$13.32▲ +8.47%
Healthcare
Other
After hours
$13.00▼ -2.40%
Oct 28, 7:57 PM ET
Volume 4.90M
Avg Volume (10D) 4.31M
Key Metrics & Fundamentals
Market Cap
$1.87B
P/E Ratio
–
Div Yield
0.00%
52W Range
7.95 - 18.48
% vs 50 MA
8.88%
% vs 200 MA
1.91%
RSI-14
62.7
MACD Histogram
+0.1100
Beta (1Y vs SPY)
2.51
Free Cash Flow
-$84.92M
Gross Rev
$7.66M
Gross Profit
$7.66M
EBITDA
-$111.01M
COGS
–
Operating Exp
$120.42M
Operating Income
-$112.76M
EBIT
-$112.76M
Pretax Income
-$106.63M
Net Income
-$106.63M
EPS (Diluted)
-0.80
Price & Volume History
Loading chart…
Recent News
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · Oct 28, 2026 4:15 PM ET
Biogen Inc. (BIIB) Tops Q3 Earnings and Revenue Estimates
Zacks · Oct 28, 2026 6:50 AM ET
Has The Story Under Krystal Biotech Stock Run Out?
Trefis · Oct 28, 2026 4:22 AM ET
The Zacks Analyst Blog Highlights BridgeBio Pharma, Intellia Therapeutics, Biogen and Viking Therapeutics
Zacks · Oct 21, 2026 8:06 AM ET
4 Biotech Stocks With Promising Late-Stage Drug Pipelines to Watch Now
Zacks · Oct 20, 2026 9:30 AM ET
Intellia Therapeutics (NTLA) Stock Looks Overvalued As Launch Preparations Advance
Simply Wall St. · Oct 18, 2026 9:13 AM ET
Cathie Wood Has Sold Nearly $18 Million of Meta in Days -- Here's What It Means
GuruFocus.com · Oct 13, 2026 11:47 AM ET
Intellia Therapeutics Appoints Jing L. Marantz, M.D., Ph.D., as Chief Medical Officer
GlobeNewswire · Oct 13, 2026 7:30 AM ET
Intellia Therapeutics (NTLA) Soars 7.6%: Is Further Upside Left in the Stock?
Zacks · Oct 9, 2026 6:51 AM ET
Why Cathie Wood Is Taking Profits on AMD Stock
Barchart · Oct 7, 2026 10:15 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See NTLA's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.